PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma
No === Neoadjuvant chemoradiotherapy (neo-CRT) prior to surgery is the standard of care for oesophageal adenocarcinoma (OAC) patients. Unfortunately, most patients fail to respond to treatment. MiR-187 was previously shown to be downregulated in neo-CRT non-responders, whist in vitro miR-187 overexp...
Main Authors: | Edge, S.D., Renard, I., Pyne, E., Moody, Hannah L., Roy, R., Beavis, A.W., Archibald, S.J., Cawthorne, C.J., Maher, S.G., Pires, I.M. |
---|---|
Language: | en |
Published: |
2021
|
Subjects: | |
Online Access: | http://hdl.handle.net/10454/18357 |
Similar Items
-
Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial
by: Bo Jan Noordman, et al.
Published: (2018-02-01) -
Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer
by: Ben M. Eyck, et al.
Published: (2021-05-01) -
Minimally invasive oesophagectomy with a total two-field lymphadenectomy after neoadjuvant chemoradiotherapy for locally advanced squamous cell carcinoma of the oesophagus: A prospective study
by: Kuppusamy Sasikumar, et al.
Published: (2021-01-01) -
MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma
by: Qiyu Luo, et al.
Published: (2021-09-01) -
2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)